Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03375086
Title A Study of APX3330 in Patients With Advanced Solid Tumors (APX3330)
Acronym APX3330
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Apexian Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.